Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis

Kory J. Lavine(Washington University in St. Louis), Brandon Ason(Amgen (United States)), Farid F. Kadyrov(Washington University in St. Louis), Tracy Yamawaki(Washington University in St. Louis), Paul C. Lee(Cornell University), Andrea Bredemeyer(Washington University in St. Louis), Vinay Penna(Washington University in St. Louis), Rafael Kramann(Brigham and Women's Hospital), Sikander Hayat(Universitätsklinikum Aachen), Chi-Ming Li(Icahn School of Medicine at Mount Sinai), Benjamin J. Kopecky(Washington University in St. Louis), Daniel Kreisel(Washington University in St. Louis), Yuriko Terada(Washington University in St. Louis), Nathan O. Stitziel(Amgen (United States)), Andrew L. Koenig(Washington University in St. Louis), Angela Fu(Amgen (United States)), Pan Ma(Washington University in St. Louis), Steven Yang, Christoph Kuppe(RWTH Aachen University), Milena B. Furtado(Amgen (United States)), Gyu Seong Heo(Mallinckrodt (United States)), Cameran Jones(Washington University in St. Louis), Yongjian Liu(Washington University in St. Louis), Junedh Amrute(Amgen (United States)), Xin Luo(The University of Texas Southwestern Medical Center), Sally Yu Shi(Xalud Therapeutics (United States))

Research Square

January 26, 2023

Cited by 30

|Cell|2020|1.6k

|Cell|2017|982

|Nature|2020|728

|Circulation Research|2019|717

|Nature|2022|692

Related Papers